Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology. - Wikidata - awgldk - TriplyDB

Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology.

Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology.

http://www.wikidata.org/entity/Q37867543

about

Molecular Approaches to Genetically Improve the Accumulation of Health-Promoting Secondary Metabolites in Staple Crops-A Case Study: The Lipoxygenase-B1 Genes and Regulation of the Carotenoid Content in Pasta Products Need for a paradigm shift in therapeutic approaches to CNS injury Diabetes alters KIF1A and KIF5B motor proteins in the hippocampus Aftins increase amyloid-β42, lower amyloid-β38, and do not alter amyloid-β40 extracellular production in vitro: toward a chemical model of Alzheimer's disease?Resveratrol Attenuates Formaldehyde Induced Hyperphosphorylation of Tau Protein and Cytotoxicity in N2a Cells Can zebrafish be used as animal model to study Alzheimer's disease?Up-regulation and activation of the P2Y(2) nucleotide receptor mediate neurite extension in IL-1β-treated mouse primary cortical neurons P2Y receptors in Alzheimer's disease.Purinergic receptors as potential therapeutic targets in Alzheimer's disease.MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect.Cornel Iridoid Glycoside Attenuates Tau Hyperphosphorylation by Inhibition of PP2A Demethylation Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3β phosphorylation in a tau transgenic Drosophila model of Alzheimer's disease.Neuroinflammation in Alzheimer's disease: an understanding of physiology and pathology.Recent advances in autophagy-based neuroprotection.Extrasynaptic NMDA receptor-induced tau overexpression mediates neuronal death through suppressing survival signaling ERK phosphorylation.Differential expression of proteins in brain regions of Alzheimer's disease patients.Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3β pathway in streptozotocin-induced alzheimer rat model.Parkinson's disease-associated PINK1 G309D mutation increases abnormal phosphorylation of Tau.

P2860

Q26741819-DEF03D74-F7D6-4A56-94BF-63DF93D1E1C4 Q27025042-40877845-1776-49CF-A636-815627F31A83 Q28567468-745562E7-AD76-4E70-85BE-6D63CAA930AB Q28828789-87341A0B-B327-4F7D-8079-CF32FD9680FB Q30363322-B5F0D88F-17A4-415D-82FA-B4EB52983442 Q30458465-51E4FC5E-9800-4393-87F0-253E5A80A536 Q30540447-7DC1986F-FA52-44EC-BE4E-7A61B688AFA9 Q34860664-2AA56093-5A98-4AB6-8086-4687C2169DDE Q36844881-90793382-F03B-429E-86C9-82C66F62BF69 Q36934113-611E2A4D-E40B-445A-B38D-BA4D8FDEA34B Q37098664-3B078DAD-4B57-463D-930E-E26962A1B608 Q37433111-5B97E862-212B-42CB-90D2-E7A18C6B14DA Q37449999-E9168737-F1D8-4130-AFF2-0B6AB39EFD9F Q38126949-CE5B7916-5FB2-46C6-800C-5164280A1D95 Q38329808-177CAFD5-AA3B-462D-A70A-D2B6384A5AF7 Q42328278-664AB6C0-B56C-4C8B-95B2-F68C6C174A83 Q43809348-69C172D5-D171-4530-9173-9CB6A1D1C438 Q50703534-73427F21-9DEC-4F76-BED0-301DB84FEDE7 Q54276344-D02675FB-AF93-470A-B6C9-7AD7BDD9CDD6

P2860

Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology.

http://www.wikidata.org/entity/Q37867543

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology.

@en

Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology.

@nl

type

label

Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology.

@en

Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology.

@nl

prefLabel

Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology.

@en

Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology.

@nl

P1433

Q37867543-54CD7FE3-39CE-4BF7-AF8C-24A0A6B21774

P1476

Q37867543-6552BC9B-DE68-4B22-9ECC-90C5EAC9AB19

P2093

Q37867543-21F69747-280D-4237-AF28-43FB0C856E8A

Q37867543-7A38715C-A94D-4C0D-998A-FAA2D7741D53

Q37867543-EDD801E0-EF39-40FF-A202-38F69D1E0B12

P2860

Q37867543-0AB79455-605B-402F-B526-0546907DED89

Q37867543-114BFC01-BAA1-4232-B816-6137BFE198E3

Q37867543-135B4F9D-1B93-4F0A-B93D-4683EAB69038

Q37867543-13FD2E0A-4DE7-4A80-92C1-2E46F9C5FC63

Q37867543-15E9FDC1-F305-4928-B300-6E38C2058A7B

Q37867543-175B494D-3F0C-44B7-85E9-D90FB8702A61

Q37867543-17DB292A-032E-45BC-AC4F-A5512394BC29

Q37867543-1A92D5A9-3848-4AA7-A172-91C25189F787

Q37867543-1AD31B39-BEC5-4E71-8197-8EC16E30F751

Q37867543-1E600942-BDF6-48B0-BA99-34EEA9731E5E

P2888

Q37867543-CF6657B1-7E91-48BC-BBEC-2EE19F3A1CD2

P304

Q37867543-DD971766-007C-471D-B94F-B9590653893E

P31

Q37867543-530C32D7-D1EF-473A-8061-2857789ACAE4

P356

Q37867543-10CB72D1-CC5A-4E24-887F-E80473BF142C

P433

Q37867543-9863DF10-67BC-413C-AAFA-A788854C6245

P478

Q37867543-67B184BF-E4E6-4C3C-9C80-2774BD668542

P577

Q37867543-44AAA7D4-C54A-48F7-8023-83102702F99E

P5875

Q37867543-B8220462-ACB1-43B1-AE38-58806C0E6D96

P698

Q37867543-774C4A0A-385A-4B56-82E5-4BB66FBBC4E8

P921

Q37867543-221ae150-2d4e-4de8-9a8d-96df94377741

Q37867543-607FE135-870F-4CEE-BDCD-AC573C66FEFA

P356

S11064-011-0475-5

P1433

Neurochemical Research

P1476

Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology.

@en

P2093

M Obulesu

http://www.w3.org/2001/XMLSchema#string

R Somashekhar

http://www.w3.org/2001/XMLSchema#string

R Venu

http://www.w3.org/2001/XMLSchema#string

P2860

A protein factor essential for microtubule assembly

Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease

Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing

Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease

Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules

Altered microtubule organization in small-calibre axons of mice lacking tau protein

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

Tau suppression in a neurodegenerative mouse model improves memory function

P2888

s11064-011-0475-5

P304

1329-1335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11064-011-0475-5

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51066909

http://www.w3.org/2001/XMLSchema#string

P698

21509508

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease